Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2011

Dec 16, 2011

30786_dirs_2011-12-16_b1cc4d10-c559-4a8d-b8c4-a6af7ab4ee8e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2011-12-14

Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-12-14 Bio-Rad B Common Stock M 2072 $28.88 Acquired 93869 Direct
2011-12-14 Bio-Rad B Common Stock F 1324 $89.31 Disposed 92545 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-12-14 Non-Qualified Stock Option (right to buy) $28.88 M 2072 Disposed 2012-02-06 Bio-Rad B Common Stock (2072) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 411252 Direct
Bio-Rad B Common Stock 12146 Indirect
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 13726 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The shares are held by a limited partnership of which the reporting person is a limited partner.

F4: The stock option vested in five equal annual installments beginning on February 6, 2003.